ApprovalTrail

Approval · Notice of Compliance 1889 · 2003

LONITEN: Notice of Compliance 1889

Issued September 29, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1889
Date
September 29, 2003
Company
Pfizer Canada UlcKirkland, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Antihypertensive

Products in this notice

BrandDINStatus today
LONITEN00514497Marketed
LONITEN00514500Marketed

Medicinal ingredients